3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
12
Phase 2
6
Phase 1/2
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 4
1
Phase 2/3
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Anus Neoplasms
2
Virus Diseases
1
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Interventions
apaziquone
1
Mitomycin
1
Interferon-alpha
1
BCG Vaccine
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Non-Muscle Invasive Bladder Neoplasms
×
Mitomycin
×
Clear all
NCT01920269
2013-08-09
EMDA/MMC
University of Rome Tor Vergata
Phase 2/3
Completed
331 enrolled